Скачать или смотреть Key transplantation updates at EHA 2021

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, talks on key updates in the field of stem cell transplantation at EHA 2021, in particular highlighting a study which investigated the prediction of transplantation outcomes in acute lymphoblastic leukemia (ALL) using a novel scoring system which incorporated disease status, phenotype and measurable residual disease (MRD) assessment. Prof. Nagler also comments on advances in the management of graft-versus-host disease (GvHD) and novel drugs for the prevention of relapse after transplantation. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.